GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Interest Expense

D&D Pharmatech (XKRX:347850) Interest Expense : ₩-471 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. D&D Pharmatech's interest expense for the three months ended in Dec. 2024 was ₩ -131 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-471 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. D&D Pharmatech's Operating Income for the three months ended in Dec. 2024 was ₩ -6,861 Mil. D&D Pharmatech's Interest Expense for the three months ended in Dec. 2024 was ₩ -131 Mil. D&D Pharmatech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

D&D Pharmatech Interest Expense Historical Data

The historical data trend for D&D Pharmatech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Interest Expense Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial -5,711.54 -1,011.55 -2,958.86 -1,426.82 -614.83

D&D Pharmatech Quarterly Data
Dec18 Dec19 Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -150.37 -154.10 -150.48 -189.36 -130.88

D&D Pharmatech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-471 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D&D Pharmatech  (XKRX:347850) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

D&D Pharmatech's Interest Expense for the three months ended in Dec. 2024 was ₩-131 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-6,861 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩6,180 Mil.

D&D Pharmatech's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

D&D Pharmatech did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

D&D Pharmatech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Interest Expense
Comparable Companies
XKRX:085660 XKRX:115450 XKRX:005250 XKRX:005690 XKRX:358570 XKRX:226950 XKRX:215600 XKRX:048410 XKRX:053030 XKRX:950210 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
Website
http://www.ddpharmatech.com
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech Headlines

No Headlines